MDM2 INHIBITORS FOR USE IN THE TREATMENT OR PREVENTION OF HEMATOLOGIC NEOPLASM RELAPSE… Application WO-2022058605-A1 World Intellectual Property Organisation (WIPO) 24 Mar 2022